“…Many articles have provided a detailed discussion on the newer-generation nontargeted activatable [6][7][8] and targeted organic fluorophores [9][10][11], gadolinium-labeled dendrimers [12][13][14] and other nanocarriers [15], and macromolecular agents [14,[16][17][18][19][20][21], including dual-modality particle imaging probes for use in image-guided procedures. One of these newer generation hybrid particle probes, C dots, an ultrasmall, cancer-targeted, fluorescent silica particle, exhibits unique physicochemical and photophysical properties, which can be exploited in a variety of surgically driven and/or minimally invasive/interventional settings.…”